Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Deluxe | DLX | Oct 30, 2024 | 19.36 | +0.73 |
Denali Capital Acquisition A | DECA | Oct 30, 2024 | 11.60 | +0.78 |
Denali Capital Acquisition Unit | DECAU | Oct 30, 2024 | 11.53 | 0.00 |
Denali Therapeutics | DNLI | Oct 30, 2024 | 26.85 | -2.26 |
Denison Mines | DNN | Oct 30, 2024 | 2.15 | -0.46 |
Dennys | DENN | Oct 30, 2024 | 6.62 | +0.15 |
DENTSPLY SIRONA | XRAY | Oct 30, 2024 | 23.41 | +0.77 |
Dermata Therapeutics | DRMA | Oct 30, 2024 | 1.35 | -2.88 |
Descartes Systems Group | DSGX | Oct 30, 2024 | 106.47 | -0.81 |
Design Therapeutics | DSGN | Oct 30, 2024 | 5.57 | +2.96 |
Designer Brands A | DBI | Oct 30, 2024 | 5.32 | -0.75 |
Desktop Metal A | DM | Oct 30, 2024 | 4.90 | -0.20 |
Despegar.com | DESP | Oct 30, 2024 | 14.50 | -1.36 |
Destiny Tech100 | DXYZ | Oct 30, 2024 | 11.36 | 0.00 |
Destra Multialternative Fund | DMA | Oct 30, 2024 | 8.66 | +0.12 |
Deswell Industries | DSWL | Oct 30, 2024 | 2.64 | +0.25 |
Deutsche Bank | DB | Oct 30, 2024 | 16.75 | -1.47 |
Dev Mkts Ex-US Alphadex First Trust | FDT | Oct 30, 2024 | 56.14 | -0.16 |
Dev Mkts Ex-US SC Alphadex First Trust | FDTS | Oct 30, 2024 | 41.52 | +0.45 |
Devon Energy | DVN | Oct 30, 2024 | 38.35 | +0.55 |
DexCom | DXCM | Oct 30, 2024 | 71.80 | -0.61 |
DHI Group | DHX | Oct 30, 2024 | 1.75 | -0.57 |
DHT | DHT | Oct 30, 2024 | 10.29 | -2.83 |
Diageo ADR | DEO | Oct 30, 2024 | 127.75 | -1.85 |
DiaMedica Therapeutics | DMAC | Oct 30, 2024 | 4.36 | +0.93 |
Diamond Hill Investment Group A | DHIL | Oct 30, 2024 | 155.04 | -1.00 |
Diamondback Energy | FANG | Oct 30, 2024 | 176.65 | +0.58 |
DiamondRock Hospitality | DRH | Oct 30, 2024 | 8.89 | +0.57 |
Diamondrock Hospitality A Pref | DRH-A | Oct 30, 2024 | 25.95 | +0.76 |
Diana Shipping | DSX | Oct 30, 2024 | 2.18 | -2.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.